GlobalData on MSN5mon
Travere pauses enrolment in Phase III homocystinuria treatment trialTravere Therapeutics has voluntarily paused subject enrolment in the Phase III HARMONY Study of pegtibatinase to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback